Other
Kay Hagan Tick Reauthorization Act
This bill extends federal funding through 2030 for programs that research, track, and fight diseases spread by ticks and mosquitoes, such as Lyme disease and West Nile virus. It continues support for regional research centers that study insect-borne illnesses and provides grants to state, local, and tribal health departments to improve testing and outbreak response. The legislation also updates the consultation process for health officials when developing national disease prevention plans.
People affected—Not determinable from the text provided.
Fiscal magnitude—CBO cost estimate published (S. 2398, Kay Hagan Tick Reauthorization Act, 2026-01-29); dollar figure pending review extraction — see receipt
Reach25provisional · pending reviewrigor: heuristic llm
What this bill touches.
Spending vs. restraint+28Public R&D+32
Who it helps · who it burdens.
Who it helps
- Regional centers of excellence in vector-borne diseasesSec. 2(a)(3) reauthorizes federal funding for regional centers of excellence dedicated to research and prevention of vector-borne diseases through fiscal year 2030.
- State, local, and tribal health departmentsSec. 2(b) reauthorizes federal grant funding through fiscal year 2030 to help health departments track, prevent, and respond to tick-borne and other vector-borne diseases.
- Centers for Disease Control and Prevention (CDC)Sec. 2(a)(2) specifies that federal grants for regional centers of excellence are administered directly through the CDC.
Who it burdens
- Tick-Borne Disease Working GroupSec. 2(a)(1) removes the statutory mandate requiring federal officials to specifically consult with this working group when updating the national vector-borne disease strategy.